Close Menu

NEW YORK – NeuMoDx announced Monday its multiplex RT-PCR SARS-CoV-2 test received CE marking.

The NeuMoDx SARS-CoV-2 Assay detects SARS-CoV-2 RNA from the Nsp2 gene and N gene in nasopharyngeal, oropharyngeal, or nasal swab specimens. The test runs on the NeuMoDx 288 and 96 Molecular Systems with results in 80 minutes from primary collection or daughter tubes, the company said. The systems can run up to 288 patient samples and can be used by laboratories to validate their own laboratory-developed tests, NeuMoDx added. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.